Carregant...
The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
One of the most common tumors in the world is hepatocellular carcinoma (HCC), and its mortality rates are still on the rise, so addressing it is considered an important challenge for universal health. Despite the various treatments that have been developed over the past decades, the prognosis for ad...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7793963/ https://ncbi.nlm.nih.gov/pubmed/33425759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.601661 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|